Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Federal Labor Secretary Promises to Assist Those Pardoned for Cannabis Crimes Find Jobs

Last week, a pair of cabinet members in the Biden administration discussed the president’s new marijuana initiative. Cabinet members and legislators, as well as advocates and state officials, have widely praised President Joseph Biden for his action.

Marty Walsh, U.S. Labor Secretary, stated in an interview with Yahoo Finance that officials were working hard to make sure that individuals who received pardons for federal cannabis offenses under the decree made by President Biden weren’t hindered from employment opportunities in the future. Walsh explained that the Department of Labor was focused on ensuring that what the president said was carried out, noting that individuals of color made up a disproportionate fraction of those who had been criminalized over marijuana.

Walsh, the former mayor of Boston, had opposed the ballot measure introduced in 2016 to legalize cannabis in Massachusetts. Walsh also voted against a party plank by the Democratic National Committee that endorsed the initiative.

Last week Biden observed the workforce implications of marijuana convictions, noting that thousands of individuals who had been convicted of simple possession who may have been denied housing, educational or employment opportunities as a result of their conviction, would be granted relief under his edict. Separately, Xavier Becerra, secretary of the Department of Health and Human Services, also discussed Biden’s directive to agencies to carry out an administrative review of marijuana’s scheduling status. The health secretary stated that officials would work as fast as they could to finish the analysis, which would probably result in a recommendation to de-schedule or reschedule cannabis.

Becerra added that he’s already spoken to FDA Commissioner Robert Califf about starting the process. Becerra also stated in a tweet that he anticipated working with U.S. Attorney General Merrick Garland to answer the president’s call to action to review how cannabis was scheduled federally.

A spokesperson for the Department of Justice also stated that the department would quickly administer the president’s proclamation, which pardoned people who engaged in simple cannabis possession by restoring the civil, political and other rights of individuals convicted of this particular offense.

Further, Rahul Gupta, director of the White House Office of National Drug Control Policy, praised Biden’s decree, observing that it was clear that the currently used cannabis laws hadn’t worked and a new approach was needed.

The comments of support from agency officials show that the Biden administration is keen on following through on the reform that was announced, with roughly a month left to Election Day.

These social justice efforts are part of what the marijuana industry and entities such as Flora Growth Corp. (NASDAQ: FLGC) have longed to see being implemented so that the country can move on and heal from the adverse effects of prohibition.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Biden Health Secretary Tasked FDA to Move Quickly on Cannabis’ Scheduling Review

Xavier Becerra, the U.S. Health & Human Services Secretary, revealed during a Meet & Greet event in Tampa, Florida, that his agency is prepared to move quickly to implement the review of marijuana’s status as a Schedule 1 drug. This comes after President Joe Biden issued a directive ordering that the scheduling of marijuana in the Controlled Substances Act be reviewed.

Speaking to reporters, the health secretary asserted that the nation will see the speed with which the review will be conducted. However, Becerra was quick to add that at the end of the day, science would be the deciding factor regarding the conclusions of the review process.

The directive calling for a review of the categorization of marijuana was one of the announcements that the president made last week. He also announced that the federal government was going to pardon all those convicted in federal court for simple cannabis possession. The Justice Department was tasked with designing mechanisms through which these pardons would be granted. Biden then called on governors around the country to emulate this step and also consider granting pardons to those with minor cannabis-related convictions.

Becerra revealed that the job of conducting the review per the president’s order will go to the U.S. Food & Drug Administration. The HHS secretary said he had already talked to Commissioner Robert Califf of the FDA about starting the review process. Becerra then commented that while conducting such a review wasn’t a new thing, the amount of information to collect is significant because so many states have implemented medical or recreational marijuana programs over the years.

At the moment, a total of 19 states have recreational or adult-use marijuana markets while an additional five will decide whether to legalize recreational cannabis during the upcoming polls in November. Another 18 states also have medicinal cannabis programs.

Despite this wave of marijuana legalization across the country, most financial institutions are reluctant to accept marijuana businesses as clients for fear that they will face the wrath of federal authorities; federal policy maintains that cannabis is strictly prohibited and doesn’t have any known medical application.

The entire cannabis industry, including actors such as Prime Harvest Inc., will probably be waiting with bated breath to see how quickly the scheduling review is conducted and what recommendations will be made for implementation by the federal government. Hopefully, the process will not drag on endlessly for years.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest Inc. are available in the company’s newsroom at https://cnw.fm/PRIME

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Pipeline Addressing Severe Unmet Patient Needs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a biotechnology company focusing its attention and resources on pursuing the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients, developed the patented DehydraTECH(TM) drug delivery technology. “The company has evidenced, through in-vivo, in-vitro and pre-clinical testing, that DehydraTECH delivers more APIs at a faster rate than controls, enabling more effective drug absorption. The testing has so far involved APIs such as cannabidiol (‘CBD’), PDE5 inhibitors, antiviral drugs, and nicotine, each at different stages of product development. This DehydraTECH pipeline, Lexaria says, is addressing severe unmet patient needs. Its DehydraTECH-CBD compound, for example, specifically targets the hypertension space,” reads a recent article. “In the U.S., about 47% of adults, or 116 million people, have hypertension, with only about 24% having the condition under control, while globally, hypertension affects more than 1 billion people, or about 30% of the adult population… Heightened blood pressure has several consequences, including the fact that it makes arteries less elastic, effectively damaging them. This damage, in turn, decreases the blood flow and oxygen to the heart, leading to heart disease. The decreased blood flow also increases the risk of stroke. In extreme cases, hypertension causes death.”

To view the full article, visit https://cnw.fm/sc0lX

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 27 patents granted and roughly 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – SHF Holdings Inc. (NASDAQ: SHFS) Continues Trading on the Nasdaq After Successful Business Combination

SHF Holdings (NASDAQ: SHFS), formerly known as Northern Lights Acquisition Corp. (“NLIT”), a special purpose acquisition company, recently completed its acquisition of SHF LLC, d/b/a Safe Harbor Financial, a leader in offering compliance services to financial institutions that serve the regulated cannabis industry. With the transaction now complete, the company has changed its name to “SHF Holdings Inc.,” with its Class A Common Stock and warrants continuing to trade on the Nasdaq Capital Market. “With its established leadership position in cannabis-related compliance services and continued growth in its financial institution clients, this is an exciting time for Safe Harbor to become part of a Nasdaq-listed company,” said John Darwin, co-CEO of NLIT prior to the closing.

To view the full press release, visit https://cnw.fm/2tr2y

About Northern Lights Acquisition Corp.

The company was formed as a special purpose acquisition company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. For more information, visit https://NorthernLightsAcquisitionCorp.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lift&Co. Expo Cannabis Business Conference & Trade Show Releases Limited All-Access Presale Tickets for Vancouver 2023

Canada’s leading Cannabis Conference and Trade Show, Lift&Co. Expo, invites all members of the cannabis industry and community to its upcoming Vancouver event taking place January 12-14, 2023, at the Vancouver Convention Centre. For a limited time, Lift&Co. Expo is releasing a limited number of discounted Lift Cannabis Business Conference (“LCBC”) + Expo All-Access presale tickets for $350 (regularly priced at $599).

Starting on day one, the Lift Cannabis Business Conference will tackle timely industry topics such as cannabis blockchain, brand and retailer relations, and cannabis real estate investing. It will also explore laws and regulations that need to change in time with the government review at the end of 2022.

New voices anticipated at the conference include Dr. Everton Flemmings, Founder & President of iValley Nutraceuticals; and David Goldstein, CEO of Stoke Inventory Partners. Also sharing their invaluable knowledge and insight are leading industry experts such as Jaclynn Pehota, Executive Director of The Retail Cannabis Council of Canada and George Smitherman of The Cannabis Council of Canada.

Continuing on days two and three, the Expo will showcase 200+ exhibiting companies from across the full “seed to sale” spectrum in a high-energy setting. In addition, the event is legendary for its networking opportunities, offering attendees the chance to establish ties among businesses, traders, vendors, cultivators, and more. 

Indeed, ever-growing audiences join in every year to be a part of this larger-than-life event that sees packed houses and a well-planned agenda. The experience at the Lift&Co. Expo is unmatched, with scintillating music, unending conversations and the free exchange of ideas. Plush amenities include multiple lounge areas, interactive booth set-ups and premium partner hotels, just to name a few.  

The presale LCBC ticket and all-access pass includes:

  • Exclusive access to Lift Cannabis Business Conference 
  • Complimentary morning and afternoon breaks and lunch
  • Industry networking reception 
  • Full access to the Exhibit Hall showcase of more than 200+ companies 
  • Full access to Exhibit Hall programming, including speakers, panels and demonstrations 
  • Full access to the new Brand Discovery Pavilion and Retailer Zone
  • Exclusive ticket to the Lift&Co. Expo After Party 

Attendees can visit the Lift&Co. Expo website to secure their presale ticket, for a limited time only.

To learn more, please visit https://liftexpo.ca/lift-co-expo-vancouver-2023/

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Patented DehydraTECH(TM) Technology to Fight America’s Silent Killer – Hypertension

  • Three out of four adults living with hypertension do not have the condition under control, putting them at risk for other serious complications
  • Lexaria’s proposed therapy for hypertension is the highly efficient DehydraTECH-CBD, which has presented with no serious adverse side effects in test participants
  • Dominated by the North American market, the global antihypertension drug market accounted for $22,557 million in 2018 and is expected to reach $28,797 million by 2026

In the United States, over 121.5 million adults are affected by high blood pressure – with statistics stacked against people of color, those with a family history of high blood pressure, heart disease, stroke, or kidney disease, and women who experienced blood pressure problems during pregnancy. According to the American Heart Association, high blood pressure is defined as a systolic pressure of 130 or higher and a diastolic pressure of 80 or higher that stays high over a period of time (https://cnw.fm/dbCLN).

For some, managing high blood pressure is as simple as changing daily habits or being proactive about monitoring it if there is a history or predisposition to the disease. Early detection can protect the brain, reducing the risk of stroke, dementia, and other vascular diseases that affect the brain. Although high blood pressure is not the only risk factor associated, being conscious of it can help preserve the brain’s blood vessels. Unfortunately, three out of four adults do not have their high blood pressure under control, creating an unmet need in the hypertension treatment market.

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is using its patented DehydraTECH(TM) technology to address the unmet needs of adults with high blood pressure (hypertension). DehydraTECH is a patented drug delivery technology that improves the oral administration of Active Pharmaceutical Ingredients (“APIs”). The benefits of using DehydraTECH-enabled APIs include the following:

  • Improvement of onset speed – effects of the drug are felt in minutes
  • Masked unwanted tastes – eliminates the need for sugar-filled edibles
  • Increased bioavailability – the technology is more effective at delivering the drug into the bloodstream
  • Increased brain absorption – testing has seen up to 27x improvement in the amount of the drug crossing the blood-brain barrier
  • Reduction in drug administration costs – the higher ratio of the drug being delivered is expected to lower the overall costs of administration

Lexaria’s initial focus on hypertension has been its DehydraTECH-CBD, which is currently in the IND enabling studies phase and is actively developing lead product pipeline candidates. The advanced hypertension program has delivered positive results with no serious adverse effects, with the most recent being completed in 2021, with 16 participants exhibiting a reduction of attenuated pulmonary artery systolic pressure of approximately 5 mmHg, or 41% overall, in male participants. The company’s corporate presentation lists all of the results – from 2018-2021 (https://cnw.fm/0by1r). Results are pending from Lexaria’s largest ever human clinical trial, where dosing completed in July.

According to Allied Market Research, the global antihypertension drug market accounted for $22,557 million in 2018 and is expected to reach $28,797 million by 2026, growing at a CAGR of 3.1% from 2019 to 2026. North America dominates the majority of the drug market. The market’s growth is expected due to the prevalence of hypertension across the globe and the interest in maintaining healthier lifestyles in the wake of the COVID-19 pandemic (https://cnw.fm/5vqaT). 

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — DEA Admits It Was Founded Based on Ethnic, Class and Racial Prejudice

These days, most pundits agree that the war on drugs is a failure. After decades of prohibition, the drug war has barely dented the illicit drug trade but contributed to the incarceration of thousands of Black people. Under prohibitionist policies, law enforcement waged a war on Black and Brown communities for decades in what some called the new Jim Crow.

Black people were and still are four times more likely to be arrested for cannabis consumption despite similar use rates as White people, and they are subject to harsher sentences. Analysis of the cannabis-related arrests that occurred in the five boroughs of New York City in 2020 revealed that Black people made up 94% of those arrested. Overall, data collected from all over the country shows that Black people are much more likely to be arrested for cannabis offenses.

The Drug Enforcement Administration (DEA) recently acknowledged that its formation was partly based on racially discriminatory drug policies. DEA Museum officials talked about the history of drug prohibition in America during the agency’s “Stories from the Collection” video series when they made the admission. They said that the DEA had been formed in alignment with punitive drug policies from the early-20th century.

The DEA Museum historian stated that public views on addiction evolved as the government began regulating drugs such as opium that originally had medical uses. Class, ethnic and racial prejudice coupled with increasing recreational drug use steadily changed public opinions, the officials said, resulting in the enactment of laws meant to curb the use of cocaine, heroin and marijuana.

The U.S. government, under the Treasury Department, formed the Federal Bureau of Narcotics (FBN) to enforce these new drug laws. FBN, which was the precursor of the DEA, enforced mostly politically and racially motivated laws in its time. For instance, law enforcement used stigmatizing and racist media depictions of cannabis to strengthen prohibition efforts. Research has also shown that communities of color were disproportionately affected by drug criminalization.

The DEA itself has now admitted that it was formed based on punitive racially motivated policies. Even while dozens of states have legalized cannabis, the DEA continues to enforce federal prohibitionist policies. Although the agency has taken steps to expand research into drugs such as psilocybin and cannabis as well as increase the number of approved cannabis growers, advocates and scientists believe the DEA remains a barrier to cannabis access.

The agency has spent the past few years fielding lawsuits over administrative policy and drug-scheduling issues, including one from a doctor who believed the DEA was breaking state and federal right-to-try laws by preventing terminally ill patients from accessing psilocybin therapy.

The prohibitionist and biased leaning of the DEA doesn’t just affect companies that are directly manufacturing and dealing in marijuana products. It also impacts ancillary companies such as Advanced Container Technologies Inc. (OTC: ACTX) because these organizations can’t grow their footprint as much as they could if marijuana laws were science based and not founded on prejudice.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — FBI Arrest Data on Cannabis Full of Inconsistencies Despite Improvements Made to Reporting System

The Federal Bureau of Investigation has spent millions of tax dollars and the last seven years updating its reporting system for crime statistics. The use of the agency’s National Incident-Based Reporting System was meant to offer clear and nationally representative data on crime trends in the country. However, the new data doesn’t give complete information, especially concerning drug arrests across America during the past year.

If anything, the end result for last year’s data raises questions for individuals tracking trends on drug enforcement, which include cannabis-related arrests. The FBI’s fragmented data on the criminalization of drugs still shows that marijuana is the main driver of the war on drugs, with cannabis and hashish making up nearly one-half of all drug-related seizures.

This is a huge gap, even if one considers that the federal agency’s Uniform Crime Reporting program has historically been limited by the fact that not all state and local law enforcement agencies consistently report their individual data or even submit it. For instance, as of April 2022, only 19 states had fully transitioned to the use of the reporting system, with 31 others having transitioned partially.

Historically, the federal agency accounted for the gaps in reporting by releasing estimates on national arrest data, which included percentage distribution breakdowns by type of drug. This year, however, there aren’t any comparable datasets that would enable analysts to estimate how many individuals had been arrested over marijuana. The data also seems to be in conflict with one another.

For instance, total drug arrests based on the public-facing data add up to 564,123, but when arrests are broken down by state, the aggregate drug-abuse violations come to 561,795. It should be noted that this doesn’t take into account how many of these violations overlapped with total arrests and neither does the data dis-aggregate drug types.

Additionally, the total number of drug/narcotic offenses for last year add up to 1,290,858 incidents, which is almost double the number of violations or drug arrests. This figure is also significantly higher and different than those from another document, which shows that in 2021 there were 707,971 drugs/narcotics offenses.

The reason why transparency and reliable figures are needed is because the federal agency’s data is relied on by the media, researchers and legislators to understand and contextualize trends of law enforcement. This, in turn, may influence how policies are crafted and implemented as well as how the public understands crime.

In an interview, Paul Armentano of NORML stated that it was inconceivable that federal agencies weren’t able to produce clear data on the estimated costs and scope of cannabis prohibition in the United States.

It is these systemic vestiges of prohibition that are holding back the marijuana industry and its various actors, such as American Cannabis Partners, from reaching their full potential facilitated by a regulatory system that is geared at supporting rather than holding back the industry.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Partnering to Expedite Exports, Increase Global Market Penetration of Colombian Cannabis Goods

Flora Growth Corp. (NASDAQ: FLGC), a global cannabis brand builder, is increasing the strengths of its supply chain, centered in its 100-hectare (about 247-acre) cultivation facility located in the heart of Colombia’s green climate, by finalizing a three-year distribution agreement with the Misak indigenous tribe’s pharmaceutical arm. “Pharma Indigena Misak Manasr Sas, referred to simply as Manasr, is the tribe’s pharmaceutical enterprise, which in 2020 became the first native community business to receive a license from the national Ministry of Justice for producing legal cannabis for medicinal and scientific use… Flora Growth will assist the tribe with regulatory advice, as well as technical and business support and market promotion for Flora Growth-branded products, particularly as the tribe enters the international supply chain,” a recent article reads. “Through this partnership, we will collaborate with the tribe on the processing and distribution of their Colombian-grown cannabis while offering Manasr a powerful platform for product distribution. In return, Flora will be able to leverage the tribe’s unique regulatory positioning to expedite exports and increase global market penetration of Colombian cannabis goods,” Flora Growth CEO and Chairman Luis Merchan is quoted as saying.

To view the full article, visit https://cnw.fm/PgLWm

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands, designed to deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands and life sciences divisions. Visit www.FloraGrowth.com or follow @floragrowthcorp on social media for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Leveraging Portfolio Data to Improve Efficiency, Profit Margins, Top-Line Sales

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is well poised as the California government shows support for the cannabis industry. “As the California legislature ended its session last month, more than a dozen cannabis reform bills were approved and sent to Governor Gavin Newsom for his consideration; ultimately, the governor signed 10 of them… According to the governor’s office, these bills ‘build on the administration’s efforts to strengthen California’s cannabis legalization framework. As part of this year’s state budget, the governor signed legislation to provide tax relief to consumers and the cannabis industry; support equity businesses; strengthen enforcement tools against illegal cannabis operators; bolster worker protections; expand access to legal retail; and protect youth, environmental and public safety programs funded by cannabis tax revenue,’” a recent article reads. “Sugarmade is focused on strengthening its presence in a variety of spaces, including cannabis. The company is rethinking metrics to leverage its portfolio data to ‘quickly and intuitively understand what we need to focus on creating today to satisfy customers tomorrow, improving efficiency, profit margins, and top-line sales.’”

To view the full article, visit https://cnw.fm/Xa7s8

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s portfolio includes CarryOutsupplies.com, SugarRush, NUG Avenue, J Grade Farm, Lemon Glow and Budcars. For more information, please visit www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SGMD

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.